NEUE IMMUNOGENISCHE PEPTIDE

Patent europeic · EP3207053 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3207053
Numer da la dumonda
EP15787917
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-10-2015
Publitgà
23-08-2017
Concedì
21-08-2019
La protecziun finescha il pli tard
15-10-2035
Proxima taxa annuala scadenta
31-10-2026
Classas IPC
C07K 14/74 (2006.01)
A61K 47/50 (2017.01)
C07K 14/47 (2006.01)
Prioritad
GB 201418433 17.10.2014
Dumonda PCT
PCT/EP2015/074063 16.10.2015
Publicaziun PCT
WO2016/059236 21.04.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-11-2025

    Midada

    Published in Swissreg on 01.11.2025

  2. 23-04-2025

    Midada

    Published in Swissreg on 23.04.2025

  3. 01-11-2023

    Midada

    Published in Swissreg on 01.11.2023

  4. 01-11-2022

    Midada

    Published in Swissreg on 01.11.2022

  5. 14-09-2019

    Represchentant inscrit

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in Swissreg on 14.09.2019

  6. 21-08-2019

    Concedì

    Published in Swissreg on 21.08.2019

Partidas

Inventur

BURKHART, David

Missoula, MT59803, US

SAINT-REMY, Jean-Marie

B-1390 Grez-Doiceau, BE

VANDER ELST, Luc

B-6230 Obaix, BE

CARLIER, Vincent

B-1350 Enines, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.